When is Norvasc (amlodipine) used to treat high blood pressure and angina?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: August 20, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

When to Use Norvasc (Amlodipine)

Norvasc (amlodipine) should be used as a first-line treatment for hypertension in most patients, and as a second-line agent for angina when beta-blockers cannot be tolerated or as an add-on therapy when angina persists despite beta-blocker treatment.

Indications for Amlodipine in Hypertension

Amlodipine is indicated for the treatment of hypertension with the following considerations:

  • Initial therapy: 5 mg once daily for most patients, with titration to 10 mg once daily if necessary for adequate blood pressure control 1
  • Lower starting dose: 2.5 mg once daily for elderly patients, those with hepatic insufficiency, or when adding to other antihypertensive therapy 1
  • Target blood pressure:
    • General target: <140/90 mmHg
    • For patients with CAD, diabetes, chronic kidney disease, or CAD risk equivalents: <130/80 mmHg 2, 1

Indications for Amlodipine in Angina

For patients with angina pectoris, amlodipine should be used according to this algorithm:

Step 1: First-line therapy

  • Beta-blockers are the preferred first-line treatment for angina due to their benefits in reducing heart failure hospitalization and mortality risk 2

Step 2: When beta-blockers cannot be used

  • Amlodipine should be considered in patients unable to tolerate a beta-blocker to relieve angina (Class IIa recommendation, Level of Evidence A) 2
  • Other alternatives include ivabradine or nitrates, but amlodipine has proven efficacy and safety in heart failure patients 2

Step 3: Add-on therapy

  • When angina persists despite beta-blocker treatment, amlodipine should be added as a second anti-anginal drug (Class I recommendation, Level of Evidence A) 2
  • Amlodipine is effective for both exertional and vasospastic angina 3, 4

Special Considerations

Heart Failure Patients

  • Amlodipine is one of the few calcium channel blockers that can be safely used in patients with heart failure and angina 2
  • Important distinction: Non-dihydropyridine CCBs (diltiazem, verapamil) should NOT be used in heart failure patients due to their negative inotropic effects and risk of worsening heart failure 2

Combination Therapy

  • Amlodipine can be added to the basic regimen of beta-blocker, ACE inhibitor, and thiazide diuretic if either angina or hypertension remains uncontrolled 2, 1
  • The combination of amlodipine with beta-blockers is safe and effective, unlike the combination of beta-blockers with non-dihydropyridine CCBs 2

Dosing and Administration

  • Starting dose: 5 mg once daily 1, 5
  • Maximum dose: 10 mg once daily 5
  • Can be taken with or without food 5
  • Once-daily dosing provides 24-hour efficacy for both hypertension and angina 3, 4

Advantages of Amlodipine

  • Long half-life allows for once-daily dosing, improving adherence 6, 7
  • Does not cause tolerance or rebound phenomena, unlike nitrates 6
  • Effectively treats both hypertension and angina, reducing polypharmacy 6
  • Gradual onset of action reduces side effects like reflex tachycardia 3
  • Safe to use with beta-blockers and other standard cardiac medications 5, 7

Common Side Effects and Monitoring

  • Monitor for peripheral edema, headache, flushing, and dizziness 1, 5
  • Check blood pressure response 7-14 days after initiation or dose changes 1
  • Watch for hypotension, particularly in elderly patients or those on multiple antihypertensive medications 1

By following these guidelines, amlodipine can be effectively used to manage hypertension and angina while minimizing risks and maximizing benefits for patient outcomes.

References

Guideline

Cardiovascular Disease Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

The efficacy of amlodipine in myocardial ischemia.

American heart journal, 1989

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.